What is Verastem Inc (VSTM) stock price today?

Verastem Inc (VSTM) currently trades at $5.46 per share. The stock has a market capitalization of $479.62M and a P/E ratio of —x.

Is VSTM stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Verastem Inc has a Smart Value Score of 20/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Verastem Inc's revenue and earnings?

Verastem Inc has trailing twelve-month (TTM) revenue of $30.91M with profit margins of 0.00%. Earnings per share (EPS) is $-3.02.

Is VSTM stock overvalued or undervalued?

Based on our DCF model, Verastem Inc's intrinsic value is $14.27, representing a margin of safety of 59.07%. The stock currently trades at a P/E of —x.

VSTM

Verastem Inc

NASDAQ: VSTM · HEALTHCARE · BIOTECHNOLOGY

$5.46

+1.11% today

Updated 2026-04-30

Market cap

$479.62M

P/E ratio

—

P/S ratio

15.51x

EPS (TTM)

$-3.02

Dividend yield

—

52W range

$4 – $11

Volume

2.0M

Market cap

$479.62M

P/E ratio

—

P/S ratio

15.51x

EPS (TTM)

$-3.02

Dividend yield

—

52W range

$4 – $11

Volume

2.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.5

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$16.38

+200.00%

12-Month target

—

Intrinsic (DCF)

$14.27

Margin of safety

+59.07%

1 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ 59.07% below intrinsic value

Risks

- Thin margins at 0.00%

- Negative free cash flow $-31.30M

- Revenue declining -78.60% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$2.60M	$0.00	$10.00M	$30.91M	$30.91M
Net income	$-73.81M	$-87.37M	$-130.64M	$-209.47M	$-32.92M
EPS	—	—	—	—	$-3.02
Free cash flow	$-63.67M	$-86.47M	$-104.80M	$-147.13M	$-31.30M
Profit margin	-2,843.30%	—	-1,306.37%	-677.59%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VSTM	$479.62M	20	5.3	2.5	6.7	5.0	+59.07%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Verastem Inc trades at $5.46. Our Smart Value Score of 20/100 indicates the stock is weak. TTM revenue stands at $30.91M. Our DCF model estimates intrinsic value at $14.27.

Frequently asked questions

What is Verastem Inc's stock price?

Verastem Inc (VSTM) trades at $5.46.

Is Verastem Inc overvalued?

Smart Value Score 20/100 (Grade F, Strong Sell). DCF value $14.27.

What is the price target of Verastem Inc (VSTM)?

The analyst target price is $16.38, representing +200.0% upside from the current price of $5.46.

What is the intrinsic value of Verastem Inc (VSTM)?

Based on our DCF model, intrinsic value is $14.27, a +59.1% margin of safety versus $5.46.

What is Verastem Inc's revenue?

TTM revenue is $30.91M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio15.51x

ROE-1,480.00%

Beta0.43

50D MA$5.76

200D MA$7.48

Shares out0.09B

Float0.07B

Short ratio—

Avg volume2.0M

Performance

1 week-2.31%

1 month+17.26%

3 months-9.08%

YTD-23.45%

1 year—

3 years—

5 years—

Compare

VSTM vs LLY →VSTM vs JNJ →VSTM vs ABBV →Stock screener →